1,506
Views
1
CrossRef citations to date
0
Altmetric
Articles

Forgetting to take HIV antiretroviral therapy: a qualitative exploration of medication adherence in the third decade of the HIV epidemic in the United States

ORCID Icon, ORCID Icon, &

References

  • Amico, K. R., Harman, J. J., & Johnson, B. T. (2006). Efficacy of antiretroviral therapy adherence interventions: A research synthesis of trials, 1996 to 2004. Journal of Acquired Immune Deficiency Syndromes, 41(3), 285–297. doi:https://doi.org/10.1097/01.qai.0000197870.99196.ea
  • Aronson, J. K. (2007). Compliance, concordance, adherence. British Journal of Clinical Pharmacology, 63(4), 383–384. doi:https://doi.org/10.1111/j.1365-2125.2007.02893.x
  • Barfod, T., Sørensen, H. T., Nielsen, H., Rodkjær, L., & Obel, N. (2006). ‘Simply forgot’ is the most frequently stated reason for missed doses of HAART irrespective of degree of adherence. HIV Medicine, 7(5), 285–290. doi:https://doi.org/10.1111/j.1468-1293.2006.00387.x
  • Beach, M. C., Roter, D. L., Saha, S., Korthuis, P. T., Eggly, S., Cohn, J., … Wilson, I. B. (2015). Impact of a brief patient and provider intervention to improve the quality of communication about medication adherence among HIV patients. Patient Education and Counseling, 98(9), 1078–1083. doi:https://doi.org/10.1016/j.pec.2015.05.011
  • Beer, L., Mattson, C. L., Bradley, H., & Skarbinski, J. (2016). Understanding cross-sectional racial, ethnic, and gender disparities in antiretroviral use and viral suppression among HIV patients in the United States. Medicine, 95(13). doi:https://doi.org/10.1097/MD.0000000000003171
  • Braun, V., & Clarke, V. (2013). Successful qualitative research: A practical guide for beginners. Thousand Oaks, CA: Sage Publications.
  • Byrd, K. K., Hou, J. G., Hazen, R., Kirkham, H., Suzuki, S., Clay, P. G., … for the Patient-Centered HIV Care Model Team (2019). Antiretroviral adherence level necessary for HIV viral suppression using real-world data. Journal of Acquired Immune Deficiency Syndrome, 82(3), 245–251. doi:https://doi.org/10.1097/QAI.0000000000002142
  • Centers for Disease Control and Prevention. (2017). More people with HIV have the virus under control [Press release]. Retrieved from https://www.cdc.gov/nchhstp/newsroom/2017/2017-HIV-Continuum-Press-Release.html.
  • Centers for Disease Control and Prevention. (2018). Understanding the HIV care continuum. Retrieved from https://www.cdc.gov/hiv/pdf/library/factsheets/cdc-hiv-care-continuum.pdf.
  • Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., & Wu, A. W. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care, 12(3), 255–266. doi:https://doi.org/10.1080/09540120050042891
  • Crepaz, N., Dong, X., Wang, X., Hernandez, A. L., & Hall, H. I. (2018). Racial and ethnic disparities in sustained viral suppression and transmission risk potential among persons receiving HIV care – United States, 2014. Morbidity and Mortality Weekly Report, 67(4), 113. doi:https://doi.org/10.15585/mmwr.mm6704a2
  • Deeks, S. G., Lewin, S. R., & Havlir, D. V. (2013). The end of AIDS: HIV infection as a chronic disease. Lancet, 382(9903), 1525–1533. doi:https://doi.org/10.1016/S0140-6736(13)61809-7
  • Dicicco-Bloom, B., & Crabtree, B. F. (2006). The qualitative research interview. Medical Education, 40(4), 314–321. doi:https://doi.org/10.1111/j.1365-2929.2006.02418.x
  • Engler, K., Lènàrt, A., Lessard, D., Toupin, I., & Lebouché, B. (2018). Barriers to antiretroviral therapy adherence in developed countries: A qualitative synthesis to develop a conceptual framework for a new patient-reported outcome measure. AIDS Care, 30(sup1), 1–12. doi:https://doi.org/10.1080/09540121.2018.1469725
  • Ernst, J. (2017). HIV over 3 decades: From fatal disease to chronic condition. Infectious Diseases in Children, 30(3), 1–5.
  • Fassin, D., & Rechtman, R. (2009). The empire of trauma: An inquiry into the condition of victimhood. Princeton, NJ: Princeton University Press.
  • Flay, B. R., Snyder, F., & Petraitis, J. (2009). The theory of triadic influence. In R. J. DiClimente, M. C. Kegler, & R. A. Crosby (Eds.), Emerging theories in health promotion practice and research (pp. 451–510). New York, NY: Jossey-Bass.
  • Flickinger, T. E., Rose, G., Wilson, I. B., Wolfe, H., Saha, S., Korthuis, P. T., … Beach, M. C. (2013). Motivational interviewing by HIV care providers is associated with patient intentions to reduce unsafe sexual behavior. Patient Education and Counseling, 93(1), 122–129. doi:https://doi.org/10.1016/j.pec.2013.04.001
  • Friedland, G. H. (1997). Adherence: The Achilles’ heel of highly active antiretroviral therapy. Improving the Management of HIV Disease, 5(1), 13–15.
  • Gadkari, A. S., & McHorney, C. A. (2012). Unintentional non-adherence to chronic prescription medications: How unintentional is it really? BMC Health Services Research, 12(1), 98. doi:https://doi.org/10.1186/1472-6963-12-98
  • Haines, C. F., Fleishman, J. A., Yehia, B. R., Lau, B., Berry, S. A., Agwu, A. L., … Gebo, K. A. (2016). Closing the gap in antiretroviral initiation and viral suppression: Time trends and racial disparities. Journal of Acquired Immune Deficiency Syndromes, 73(3), 340. doi:https://doi.org/10.1097/QAI.0000000000001114
  • Harzke, A., Williams, M., Nilsson-Schönnesson, L., Ross, M., Timpson, S., & Keel, K. (2004). Psychosocial factors associated with adherence to antiretroviral medications in a sample of HIV-positive African American drug users. AIDS Care, 16(4), 458–470. doi:https://doi.org/10.1080/09540120410001683394
  • Hseih, H. F., & Shannon, S. E. (2005). Three approaches to qualitative content analysis. Qualitative Health Research, 15(9), 1277–1288.
  • Jaiswal, J., Griffin-Tomas, M., Singer, S. N., & Lekas, H. M. (2018). Desire for patient-centered HIV care among inconsistently engaged racial and ethnic minority people living with HIV. The Journal of the Association of Nurses in AIDS Care: JANAC, 29(3), 426–438. doi:https://doi.org/10.1016/j.jana.2018.01.001
  • Jelliman, P., & Porcellato, L. (2017). HIV is now a manageable long-term condition, but what makes it unique? A qualitative study exploring views about distinguishing features from multi-professional HIV specialists in North West England. The Journal of the Association of Nurses in AIDS Care: JANAC, 28(1), 165–178. doi:https://doi.org/10.1016/j.jana.2016.09.008
  • Kalichman, S. C., Grebler, T., Amaral, C. M., McNerey, M., White, D., Kalichman, M. O., … Eaton, L. (2013). Intentional non-adherence to medications among HIV positive alcohol drinkers: Prospective study of interactive toxicity beliefs. Journal of General Internal Medicine, 28(3), 399–405. doi:https://doi.org/10.1007/s11606-012-2231-1
  • Kalichman, S. C., Kalichman, M. O., & Cherry, C. (2017). Forget about forgetting: Structural barriers and severe non-adherence to antiretroviral therapy. AIDS Care, 29(4), 418–422. doi:https://doi.org/10.1080/09540121.2016.1220478
  • Kalichman, S. C., Kalichman, M. O., Cherry, C., Hoyt, G., Washington, C., Grebler, T., … Merely, C. (2015). Intentional medication nonadherence because of interactive toxicity beliefs among HIV-positive active drug users. Journal of Acquired Immune Deficiency Syndromes, 70(5), 503–509. doi:https://doi.org/10.1097/QAI.0000000000000776
  • Kuehn, B. M. (2014). Reports: HIV drugs targeted for black market. JAMA, 312(11), 1086–1087. doi:https://doi.org/10.1001/jama.2014.11153
  • LaVeist, T. A. (2005). Disentangling race and socioeconomic status: A key to understanding health inequalities. Journal of Urban Health, 82(2), iii26–iii34. doi:https://doi.org/10.1093/jurban/jti061
  • Magidson, J. F., Blashill, A. J., Safren, S. A., & Wagner, G. J. (2015). Depressive symptoms, lifestyle structure, and ART adherence among HIV-infected individuals: A longitudinal mediation analysis. AIDS and Behavior, 19(1), 34–40. doi:https://doi.org/10.1007/s10461-014-0802-3
  • Marecek, J., Fine, M., & Kidder, L. (2001). Working between two worlds: Qualitative methods and psychology. In D. L. Tolman & M. Brydon-Miller (Eds.), From subjects to subjectivities: A handbook of interpretive and participatory methods (pp. 29–41). New York, NY: New York University Press.
  • Maxwell, J. A. (2012). Qualitative research design: An interactive approach (3rd ed., Vol. 41). Thousand Oaks, CA: Sage Publications.
  • Mayer, J. E., & Fontelo, P. (2017). Meta-analysis on the effect of text message reminders for HIV-related compliance. AIDS Care, 29(4), 409–417. doi:https://doi.org/10.1080/09540121.2016.1214674
  • Miller, W., & Rollnick, S. (1991). Motivational interviewing: Preparing people to change addictive behavior. New York, NY: Guilford Press.
  • New York City Department of Health and Mental Hygiene. (2019). HIV Surveillance annual report, 2018. Retrieved from https://www1.nyc.gov/assets/doh/downloads/pdf/dires/2014-hiv-surveillance-annual-report.pdf.
  • New York State Department of Health. (2016). New York State/New York City/Long Island 2017-2021 integrated HIV prevention and care plan. Retrieved from https://www.health.ny.gov/diseases/aids/providers/reports/scsn/docs/integrated_hiv_prevention_plan.pdf.
  • Osterberg, L., & Blaschke, T. (2005). Adherence to medication. The New England Journal of Medicine, 353(5), 487–497. doi:https://doi.org/10.1056/NEJMra050100
  • Pellowski, J. A., Kalichman, S. C., Matthews, K. A., & Adler, N. (2013). A pandemic of the poor: Social disadvantage and the U. S. HIV epidemic. The American Psychologist, 68(4), 197–209. doi:https://doi.org/10.1037/a0032694
  • Rebeiro, P. F., Abraham, A. G., Horberg, M. A., Althoff, K. N., Yehia, B. R., Buchacz, K., … Design. (2017). Sex, race, and HIV risk disparities in discontinuity of HIV care after antiretroviral therapy initiation in the United States and Canada. AIDS Patient Care and STDs, 31(3), 129–144.
  • Rothbauer, P. M. (2008). Triangulation. In L. Given (Ed.), The sage encyclopedia of qualitative research methods (Vol. 2, pp. 892–894). Thousand Oaks, CA: SAGE Publications.
  • Saberi, P., Neilands, T. B., Vittinghoff, E., Johnson, M. O., Chesney, M., & Cohn, S. E. (2015). Barriers to antiretroviral therapy adherence and plasma HIV RNA suppression among AIDS clinical trials group study participants. AIDS Patient Care and STDs, 29(3), 111–116. doi:https://doi.org/10.1089/apc.2014.0255
  • Samji, H., Cescon, A., Hogg, R. S., Modur, S. P., Althoff, K. N., & Buchacz, K., … Design of IeDEA. (2013). Closing the gap: Increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One, 8(12), e81355. doi:https://doi.org/10.1371/journal.pone.0081355
  • Sauceda, J. A., Neilands, T. B., Johnson, M. O., & Saberi, P. (2018). An update on the barriers to adherence and a definition of self-report non-adherence given advancements in antiretroviral therapy (ART). AIDS and Behavior, 22(3), 939–947. doi:https://doi.org/10.1007/s10461-017-1759-9
  • Simoni, J. M., Huh, D., Wilson, I. B., Shen, J., Goggin, K., Reynolds, N. R., … Liu, H. (2012). Racial/ethnic disparities in ART adherence in the United States: Findings from the MACH14 study. Journal of Acquired Immune Deficiency Syndromes, 60(5), 466–472. doi:https://doi.org/10.1097/QAI.0b013e31825db0bd
  • Tobias, R. (2009). Changing behavior by memory aids: A social psychological model of prospective memory and habit development tested with dynamic field data. Psychological Review, 116(2), 408. doi:https://doi.org/10.1037/a0015512
  • Trickey, A., May, M. T., Vehreschild, J.-J., Obel, N., Gill, M. J., Crane, H. M., … Cazanave, C. (2017). Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: A collaborative analysis of cohort studies. The Lancet. HIV, 4(8), e349–e356. doi:https://doi.org/10.1016/S2352-3018(17)30066-8
  • Vervoort, S. C., Borleffs, J. C., Hoepelman, A. I., & Grypdonck, M. H. (2007). Adherence in antiretroviral therapy: A review of qualitative studies. Aids (London, England), 21(3), 271–281. doi:https://doi.org/10.1097/QAD.0b013e328011cb20
  • Wilson, A., & Childs, S. (2002). The relationship between consultation length, process and outcomes in general practice: A systematic review. The British Journal of General Practice, 52(485), 1012–1020.
  • Wolf, Z. R. (2003). Exploring the audit trail for qualitative investigations. Nurse Educator, 28(4), 175–178.
  • Xia, Q., Robbins, R. S., Lazar, R., Torian, L. V., & Braunstein, S. L. (2017). Racial and socioeconomic disparities in viral suppression among persons living with HIV in New York City. Annals of Epidemiology, 27(5), 335–341. doi:https://doi.org/10.1016/j.annepidem.2017.04.005
  • Yardley, L. (2000). Dilemmas in qualitative health research. Psychology & Health, 15(2), 215–228. doi:https://doi.org/10.1080/08870440008400302